, Hong Kong

Investment firm Wellington Management closes $393m biomedical fund

The fund will allot investments into private biotech companies.

Investment management firm Wellington Management has secured $393m in total proceeds from its oversubscribed Wellington Biomedical Innovation Fund I, the company announced.

The fund will invest in private biotechnology companies focusing on drug discovery and development, and will seek capital to be used for the advancement of their scientific programs.

The firm’s private investment platform now amounts to $2.7b.

The funds’ investor base includes public and private pension plans, insurance companies, corporations, and family offices.

Join Healthcare Asia Magazine community
Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!

Exclusives

Saudi’s KFSHRC banks on innovation to transform healthcare
The hospital is accelerating adoption of emerging technologies to position itself as a global leader in medicine
Angkor Hospital eyes trauma centre for children
The facility will have an ICU, emergency room, operating theatre and a surgical ward.